Built to help voters quickly verify how officials vote — district first, party second. All information is sourced from official public records.
HR. 1107 · 119th Congress

Protecting Veteran Access to Telemedicine Services Act of 2025

In committee

This bill has not become law. Status shown reflects the latest official action.

See what this could mean for your district

Save your district in Account to view district-specific context for this bill.

Bill details

Introduced: 2/6/2025
Status: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Bill ID: 119hr1107
Latest action: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Summary

Introduced in House

Protecting Veteran Access to Telemedicine Services Act of 2025 This bill permanently authorizes certain Department of Veterans Affairs (VA) health care professionals to use telemedicine to deliver, distribute, or dispense controlled substances that are prescription drugs to patients who are eligible for VA health care, regardless of whether the health care professional has conducted an in-person medical examination. The health care professional must be (1) authorized to prescribe the basic class of such controlled substance under an active, current, full, and unrestricted license or certification; (2) acting in the usual course of professional practice; and (3) delivering, distributing, or dispensing the substance for a legitimate medical purpose.

Source: BILLSUM · Summary date: 2/6/2025

District impact notes

1 notes
NEUTRAL
3/16/2026

The Protecting Veteran Access to Telemedicine Services Act of 2025 allows certain VA health care professionals to prescribe controlled substances via telemedicine without an in-person examination. • This change could improve access to necessary medications for veterans in the district who may have difficulty attending in-person appointments. • Local health care providers may need to adapt their practices to accommodate this new telemedicine framework for prescribing controlled substances. • There may be questions about how to ensure the legitimacy of remote prescriptions and the potential for misuse of controlled substances. AI-generated from official bill summary and plain-English note; verify with official text.

Related votes

Roll calls that reference this bill in official data.

0 roll calls
No related roll calls found yet for this bill.

Primary sources

Official links to verify details. (No interpretation.)

Summary source label: BILLSUM
About this data
  • OurCongress is non-partisan by design. We do not add political interpretation or advocacy.
  • Bill data and official summaries come from GovInfo and Congress.gov. Some bills do not have published summaries yet.
  • District impact notes (when shown) are AI-generated from official bill metadata/summaries to improve readability. They are not official government language.
  • This page updates automatically via a daily ingestion pipeline.

About this data

Non-partisan by design
OurCongress provides plain-English context without endorsements, political interpretation, or advocacy.
Official sources
Data is sourced from official government records (e.g., Congress.gov, GovInfo, Clerk of the House, and the U.S. Senate).
AI-generated text
Some sections may be AI-generated from official summaries/metadata to help readability. AI output can be imperfect—verify with primary sources.
Last updated: 3/16/2026Source: BILLSUMBill: 119hr1107Learn more →